| 摘要 |
The invention relates to medicine, in particular to neurology and oncology and may be used for differential diagnostics of astroglial and oligodendroglial tumors.According to the invention, the claimed method consists in that it is performed the spectroscopy by nuclear magnetic resonance with determination of the spectrum indicating the amount of 2-hydroxy-glutaric and lactic acid, then is determined the ratio between their values and in the case where the result is of 0.1…0.9 it is diagnosticated an oligodendroglial tumor, and in the case where it is greater than 1.0 - an astroglial tumor. |
